Page 9 of 14 – SEC Filing CUSIP No. 87184Q107 13G Page 9 of 11
(f) o An employee benefit plan or endowment fund in accordance with Rule 13d-1(b)(1)(ii)(F);
(g) o A parent holding company or control person in accordance with Rule 13d-1(b)(1)(ii)(G);
(h) o A savings association as defined in Section 3(b) of the Federal Deposit Insurance Act;
(i) o A church plan that is excluded from the definition of an investment company under Section 3(c)(14) of the Investment Company Act;
(j) o A non-U.S. institution in accordance with Rule 13d-1(b)(1)(ii)(J);
(k) o Group, in accordance with Rule 13d-1(b)(1)(ii)(K).
If filing as a non-U.S. institution in accordance with Rule 13d-1(b)(1)(ii)(J), please specify the type of institution: _________________ Item 4. Ownership.
Provide the following information regarding the aggregate number and percentage of the class of securities of the issuer identified in Item 1. (a) Amount beneficially owned**: Deerfield Mgmt, L.P. – 628,566 shares Deerfield Mgmt III, L.P. – 1,466,654 shares Deerfield Management Company, L.P. – 2,095,220 shares Deerfield Special Situations Fund, L.P. – 628,566 shares Deerfield Private Design Fund III, L.P. – 1,466,654 shares James E. Flynn – 2,095,220 shares (b) Percent of class**: Deerfield Mgmt, L.P. – 2.69% Deerfield Mgmt III, L.P. – 6.28% Deerfield Management Company, L.P. – 8.97% Deerfield Special Situations Fund, L.P. – 2.69% Deerfield Private Design Fund III, L.P. – 6.28% James E. Flynn – 8.97%
(c) Number of shares as to which such person has**: (i) Sole power to vote or to direct the vote: All Reporting Persons – 0 (ii) Shared power to vote or to direct the vote: Deerfield Mgmt, L.P. – 628,566 shares Deerfield Mgmt III, L.P. – 1,466,654 shares Deerfield Management Company, L.P. – 2,095,220 shares Deerfield Special Situations Fund, L.P. – 628,566 shares Deerfield Private Design Fund III, L.P. – 1,466,654 shares James E. Flynn – 2,095,220 shares
Follow Syros Pharmaceuticals Inc.
Follow Syros Pharmaceuticals Inc.
We may use your email to send marketing emails about our services. Click here to read our privacy policy.
| CUSIP No. | 87184Q107 | 13G | Page 9 of 11 |
| (f) | o | An employee benefit plan or endowment fund in accordance with Rule 13d-1(b)(1)(ii)(F); | |
| (g) | o | A parent holding company or control person in accordance with Rule 13d-1(b)(1)(ii)(G); |
| (h) | o | A savings association as defined in Section 3(b) of the Federal Deposit Insurance Act; |
| (i) | o | A church plan that is excluded from the definition of an investment company under Section 3(c)(14) of the Investment Company Act; |
| (j) | o | A non-U.S. institution in accordance with Rule 13d-1(b)(1)(ii)(J); |
| |
| (k) | o | Group, in accordance with Rule 13d-1(b)(1)(ii)(K). |
If filing as a non-U.S. institution in accordance with Rule 13d-1(b)(1)(ii)(J), please specify the type of institution: _________________
| Item 4. | Ownership. |
Provide the following information regarding the aggregate number and percentage of the class of securities of the issuer identified in Item 1.
| (a) | Amount beneficially owned**: | ||
| Deerfield Mgmt, L.P. – 628,566 shares Deerfield Mgmt III, L.P. – 1,466,654 shares Deerfield Management Company, L.P. – 2,095,220 shares Deerfield Special Situations Fund, L.P. – 628,566 shares Deerfield Private Design Fund III, L.P. – 1,466,654 shares James E. Flynn – 2,095,220 shares | |||
| (b) | Percent of class**: | ||
| Deerfield Mgmt, L.P. – 2.69% Deerfield Mgmt III, L.P. – 6.28% Deerfield Management Company, L.P. – 8.97% Deerfield Special Situations Fund, L.P. – 2.69% Deerfield Private Design Fund III, L.P. – 6.28% James E. Flynn – 8.97% |
| (c) | Number of shares as to which such person has**: | ||||
| (i) | Sole power to vote or to direct the vote: | All Reporting Persons – 0 | |||
| (ii) | Shared power to vote or to direct the vote: | Deerfield Mgmt, L.P. – 628,566 shares Deerfield Mgmt III, L.P. – 1,466,654 shares Deerfield Management Company, L.P. – 2,095,220 shares Deerfield Special Situations Fund, L.P. – 628,566 shares Deerfield Private Design Fund III, L.P. – 1,466,654 shares James E. Flynn – 2,095,220 shares | |||
Follow Syros Pharmaceuticals Inc.
Follow Syros Pharmaceuticals Inc.
We may use your email to send marketing emails about our services. Click here to read our privacy policy.